8th Circ. Reinstates Investors' Claims Against KV Pharma
The Eighth Circuit on Monday gave new life to a shareholder class action against KV Pharmaceutical Co., reviving claims that the drugmaker misled investors by failing to disclose myriad problems with...To view the full article, register now.
Already a subscriber? Click here to view full article